Search

everythinglearnresearchcommunity

for

Search:↓

Cathelicidins could treat skin issues but face challenges like safety and resistance.

A new method effectively detects trace sex hormones in cosmetics, ensuring safety.

Electrospun nanofiber membranes are promising for non-invasive medical uses like tissue repair and health monitoring.

Machine learning improves DNA predictions for eye and hair color, but challenges remain for skin tone and facial features.

Single-spin and double-spin PRP methods are equally effective for treating hair loss.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Sorafenib and Platycladus orientalis leaf extract together effectively suppress cervical cancer cell growth.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Male pattern baldness may predict prostate cancer risk.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.